News Snapshot:
As four vaccines from China undergo human trials, trust and cost issues threaten their widespread supply China has promised to meet certain countries’ needs, but ‘vaccine nationalism’ and hostilities with the US may complicate matters Four vaccines from China are undergoing human trials, but cost, ‘vaccine nationalism’ and hostilities with the US may complicate their widespread supply. China is among the world’s front-runners in developing Covid-19 vaccines. Its indications that mass production of vaccines is imminent has raised questions about capacity, efficacy and availability. Out of 300 vaccine candidates around the world, nine are in phase 3 human trials, according...
